Leo Groenewegen
Algemeen Directeur bij NBAB, Nordic BioAnalysis AB
Profiel
Leo Groenewegen is currently the Chief Executive Officer at NBAB, Nordic BioAnalysis AB.
Prior to this, he worked as the Chief Financial Officer at NextCell Pharma AB.
Actieve functies van Leo Groenewegen
| Bedrijven | Functie | Begin |
|---|---|---|
NBAB, Nordic BioAnalysis AB
 NBAB, Nordic BioAnalysis AB BiotechnologyHealth Technology Part of Ilya Pharma AB, NBAB, Nordic BioAnalysis AB engages in bio analytical development, validation and analysis of medicines. The company is based in Södertälje, Sweden. The Swedish company was founded in 2010. The CEO is Leo Groenewegen. NBAB was acquired by Ilya Pharma AB on April 19, 2022. | Algemeen Directeur | 01-09-2022 |
Eerdere bekende functies van Leo Groenewegen
| Bedrijven | Functie | Einde |
|---|---|---|
| NEXTCELL PHARMA AB | Financieel Directeur/CFO | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NEXTCELL PHARMA AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
NBAB, Nordic BioAnalysis AB
NBAB, Nordic BioAnalysis AB BiotechnologyHealth Technology Part of Ilya Pharma AB, NBAB, Nordic BioAnalysis AB engages in bio analytical development, validation and analysis of medicines. The company is based in Södertälje, Sweden. The Swedish company was founded in 2010. The CEO is Leo Groenewegen. NBAB was acquired by Ilya Pharma AB on April 19, 2022. | Health Technology |
